Cyagen Biosciences and Vivo Bio Tech partner to provide easy access to Genomic Technologies to Indian Biomedical R&D

 

Santa Clara, USA and Hyderabad, India, Thursday, September 1, 2016 – Cyagen Biosciences a leader in custom animal models and molecular biology tools and Vivo Bio Tech, a preclinical Contract Research Organization and Specific Pathogen Free Laboratory Animal Commercial Breeder, announced that they have entered into an agreement under which Vivo Bio Tech is appointed as the Authorized Distributor of Cyagen Biosciences’ complete product and service portfolio in India. 

Through this partnership, the Indian Biomedical Scientists would have an easy access to cost-effective custom-designed and disease-specific genetically engineered rodent models at a short turnaround time to accelerate their research programs.

“We are excited to announce our new partnership with Vivo Bio Tech, a pioneer in the introduction of locally bred Specific Pathogen Free Laboratory Rodents in India. While Cyagen's clientele span the globe in over fifteen countries including India, this new partnership aims to assist Indian researchers in streamlining and advancing their research by increasing the availability of high quality custom designed animal models, custom vectors, and virus packaging service with highly competitive pricing, fast turnaround time, and excellent customer service” said Cyagen Biosciences Chairman of the Board, Mr. Lance Han.

“We are quite excited to partner with Cyagen Biosciences, one of the leading genomics company with innovative technologies like Turboknockout® - the fastest turnaround for ES-cell based gene targeting and with a track record of successfully delivering more than 2,000 transgenic projects and with a clientele in excess of 300 premier universities and companies worldwide. This partnership takes us yet another step forward towards Vivo Bio Tech’s mission to provide Indian Biomedical Scientists easy access to world class research tools and innovative technologies” said Vivo Bio Tech President Dr. A. Sankaranarayanan.

Vivo Bio Tech will distribute Cyagen’s Animal Models - TurboKnockout® Gene Targeting Mice, Transgenic Rodents, Genome Editing Knockout and Knockin Rodents, PiggyBac Transgenic Mice, Transgenic Mouse Embryos, and Cell & Media products, and Vector building & Packaging Services in India. Vivo Bio Tech shall also offer Custom Breeding and Contract Research Services using Cyagen’s Rodent Models.

About Cyagen Biosciences, Inc.
Cyagen Biosciences a CRO and cell culture product manufacturer headquartered in Silicon Valley, California, and with offices in Germany and China. The company is the world's largest provider of custom-designed transgenic and knockout mouse services with shortest turn-around time, a leader in molecular biology tools and manufacturer of research-use stem cells and related culture reagents. The company’s proprietary new technology, Turboknockout® - an ES cell mediated service provides customers with conditional knockout, reporter knockin and humanization mouse models in as little as 6-8 months.

About Vivo Bio Tech Ltd.
Vivo Bio Tech is a Hyderabad based public listed CRO offering services to biomedical industry worldwide in the areas of in-vitro / in-vivo toxicology, pharmacological investigations, analytical and physico-chemical testing. The company is also the largest supplier of locally bred Specific Pathogen Free laboratory rodents in India. The company’s state-of-art 125,000 Sq.ft. preclinical research facility is NGCMA OECD-GLP certified and AAALAC accredited.

For Media Inquiries
Cyagen Biosciences, Inc.
Dr. Austin Jelcick
Director of Marketing
P. +1-800-921-8930
E. service@cyagen.us

Vivo Bio Tech Ltd.
Mr. Kalyan Korisapati
COO & Head – BD
P. +91-8454-244-555
E. kalyan@vivobio.com

 

 

One-stop solution for all your gene targeting mouse model:

TurboKnockout® Gene Targeting - ES-based knockout mice, 100% guaranteed germline transmission, as fast as 6 months

CRISPR Knockout - Guaranteed germline transmitted F1 animals, as fast as 3 months

Transgenic Mice - More consistent expression, defined region of integration, founders as fast as 3 months